Americans are struggling to afford the buzzy weight-loss drug Ozempic.
Americans are struggling to afford the buzzy weight-loss drug Ozempic, even with insurance coverage, a new study shows.
Especially after a 2022 study found that people who stopped taking Ozempic regained two-thirds of their weight within a year.
And Medicare, the federal program that covers healthcare for people 65 and older, is prohibited by law from covering any weight-loss medications.
Meanwhile, other Americans will continue to go to Canada, Mexico, and unregulated online pharmacies to get the weight-loss medications for cheap.
Persons:
Ozempic, Utibe Essien, Essien
Organizations:
UCLA, Employers
Locations:
Canada, Mexico